DarioHealth (DRIO) vs TELA Bio (TELA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
TELA Bio (TELA) has outperformed DarioHealth (DRIO) over the past year, losing 25.0% versus a loss of 63.0%. Over five years, TELA leads with a -91.2% price change compared with -98.2% for DRIO. DarioHealth is the larger company by market cap ($56.8 million vs $50.1 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DRIO | TELA |
|---|---|---|
| Share price | $5.80 | $1.11 |
| Market cap | $56.84M | $50.11M |
| 1-day change | +4.69% | +5.71% |
| YTD return | -49.03% | -5.93% |
| 1-year return | -63.03% | -25.00% |
| 5-year return | -98.21% | -91.19% |
| EPS (TTM) | $-2.39 | $-0.77 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $16.50 | $1.56 |
| 52-week low | $5.37 | $0.501 |
| Distance from 52-week high | -64.85% | -28.85% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +134.48% | +87.39% |
| Average volume | 25.33K | 214.83K |
| Shares outstanding | 9.80M | 45.14M |
| Employees | 160 | 218 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- TELA has outperformed DRIO by 38.0 percentage points over the past year.
About DarioHealth
DRIO stock →DarioHealth Corp. operates as a digital health company in the United States and internationally.
Health Care · Medical/Dental Instruments · 160 employees
About TELA Bio
TELA stock →TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene, polyglycolic acid, and polylactic-co-glycolic acid designed to be used in laparoscopic and robotic-assisted hernia surgical repairs.
Health Care · Medical/Dental Instruments · 218 employees
DRIO vs TELA FAQ
Which is bigger, DarioHealth or TELA Bio?
DarioHealth (DRIO) is larger, with a market capitalization of $56.84M compared with $50.11M for TELA Bio (TELA).
Which stock has performed better over the past year, DRIO or TELA?
TELA returned -25.00% over the past 12 months, compared with -63.03% for DRIO (price return, excluding dividends). Past performance does not predict future results.
Are DarioHealth and TELA Bio in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.